DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. BRVE
3. OKE
4. SRE
5. CNS
6. ATTO
7. EIX
8. AON
9. HDB
10. XOM

Go back to DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
(NASDAQ: DMAC) Delayed: 6.39 --0 (-0%)
Previous Close $6.39    52 Week High $ 
Open $6.39    52 Week Low $ 
Day High $6.39    P/E N/A 
Day Low $6.39    EPS $ 
Volume 1